×
About 1,338 results

ALLMedicine™ Ventricular Septal Defects Center

Research & Reviews  495 results

Transcatheter closure of ventricular septal defects: preliminary results in children we...
https://doi.org/10.1017/S1047951122001147
Cardiology in the Young; Mirza M K, Abqari S et. al.

May 3rd, 2022 - Ventricular septal defect is one of the commonest heart defect in children and closure of this defect with devices has seen a rapid progression over a period of time. The availability of new and safer devices has made the transcatheter closure of ...

CHD4 is recruited by GATA4 and NKX2-5 to repress noncardiac gene programs in the develo...
https://doi.org/10.1101/gad.349154.121
Genes & Development; Robbe ZL, Shi W et. al.

Apr 23rd, 2022 - The nucleosome remodeling and deacetylase (NuRD) complex is one of the central chromatin remodeling complexes that mediates gene repression. NuRD is essential for numerous developmental events, including heart development. Clinical and genetic stu...

Transcatheter Myotomy to Relieve Left Ventricular Outflow Tract Obstruction: The Septal...
https://doi.org/10.1161/CIRCINTERVENTIONS.121.011686
Circulation. Cardiovascular Interventions; Khan JM, Bruce CG et. al.

Apr 6th, 2022 - Left ventricular outflow tract obstruction complicates hypertrophic cardiomyopathy and transcatheter mitral valve replacement. Septal reduction therapies including surgical myectomy and alcohol septal ablation are limited by surgical morbidity or ...

Transcatheter Versus Surgical Closure of Acute Ruptured Sinus of Valsalva Aneurysms wit...
https://doi.org/10.1007/s00246-022-02873-5 10.1016/S0022-5223(19)37013-8 10.1111/j.1540-8191.1997.tb00143.x 10.1016/S0022-5223(94)70424-4 10.1093/eurheartj/ehq323 10.1136/hrt.71.5.479 10.1016/j.amjcard.2014.11.013 10.1016/j.jtcvs.2012.12.059 10.1016/j.jjcc.2013.08.011 10.1016/j.jjcc.2019.03.012 10.4244/EIJ-D-18-00294 10.1111/chd.12572 10.1002/ccd.25323
Pediatric Cardiology; Mumtaz ZA, Sagar P et. al.

Apr 6th, 2022 - Transcatheter ruptured sinus of valsalva aneurysm (RSOVA) closure is an alternative to surgery. When a restrictive ventricular septal defect (rVSD) coexists, there are doubts about support for an occluder and persistent left ventricular (LV) dilat...

Word of caution: Severe aortic valve injury linked to retrograde closure of perimembran...
https://doi.org/10.1111/jocs.16441
Journal of Cardiac Surgery; Haddad RN, Sawan EB et. al.

Apr 3rd, 2022 - Retrograde device closure of perimembranous ventricular septal defects (pmVSDs) is an interesting procedure with several technical advantages and encouraging follow-up results. Nevertheless, aortic valve injuries may occur and require sufficient a...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  7 results

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
https://clinicaltrials.gov/ct2/show/NCT03165526

Dec 15th, 2021 - This is a multi-center, observational study to evaluate the safety and probable benefit of the AMPLATZER™ PIVSD Occluder for use in transcatheter closure of muscular ventricular septal defects following a myocardial infarction in the post approval...

Impact of Congenital Heart Disease on Neurodevelopmental Outcome
https://clinicaltrials.gov/ct2/show/NCT03871881

May 10th, 2021 - The project provides detailed information on the impact of congenital heart disease on neurodevelopmental outcome in adulthood. The study investigates if brain maturation and development, and the neurocognitive outcome is compromised in patients w...

Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
https://clinicaltrials.gov/ct2/show/NCT00583791

Jun 28th, 2019 - The objective of this feasibility study is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction w...

Evaluation of the Usefulness of Imaging Methods and 3D Reconstruction in Percutaneous Closure Procedures of PVL.
https://clinicaltrials.gov/ct2/show/NCT03371472

Jan 17th, 2019 - Transcatheter closure of PVL has emerged as a new treatment strategy that can be offered to patients with isolated PVL or to those with a very high risk of repeat surgery. The transcatheter approach involves deployment of occlude devices or coils ...

see more →

News  21 results

High Maternal Lipid Levels Tied to Congenital Heart Disease in Offspring
https://www.medscape.com/viewarticle/958291

Sep 8th, 2021 - (Reuters Health) - Women with high lipid levels during early pregnancy are at increased risk for having offspring with congenital heart disease, a new study suggests. Researchers examined data on blood lipid levels during pregnancy for 230 women w...

Simple, Repaired Heart Defect Still Hurts Long-Term Functional Capacity
https://www.medpagetoday.com/cardiology/prevention/88766

Sep 23rd, 2020 - Repairing ventricular septal defects (VSDs) in childhood did not always prevent impairments in functional capacity decades later, researchers from one center reported. Adults over age 40 had differences in exercise capacity on cardiopulmonary exer...

Study: Ondansetron Mostly Safe in Early Pregnancy
https://www.medpagetoday.com/obgyn/pregnancy/77020

Dec 19th, 2018 - Mothers who took ondansetron (Zofran) in the first trimester of pregnancy were generally not more likely to have children with congenital malformations, although a small increased risk of oral clefts was observed, according to a retrospective coho...

Beta-Blockade After MI: No Practice Should Be Set in Stone
https://www.medscape.com/viewarticle/901940

Sep 13th, 2018 - A patient presented soon after having chest pain. The electrocardiogram (ECG) showed an ST-elevation myocardial infarction (STEMI). The day after acute percutaneous coronary intervention (PCI), cardiac enzymes met the definition of myocardial infa...

Nonchromosomal Birth Defects Linked With Childhood Cancers
https://www.staging.medscape.com/viewarticle/895224

Apr 16th, 2018 - CHICAGO — In a retrospective analysis of registry data on more than 10 million live births, the risk for childhood cancers was 2.6-fold higher in children born with nonchromosomal abnormalities than in children born without any defects. In additio...

see more →

Patient Education  1 results see all →